Drug Profile
Research programme: anti-inflammatory compounds - Novartis
Alternative Names: VAF-347Latest Information Update: 21 Jul 2010
Price :
$50
*
At a glance
- Originator Novartis
- Class Amines; Chlorophenols; Pyrimidines; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 09 Aug 2006 Preclinical trials in Inflammation in Austria (unspecified route)
- 09 Aug 2006 Preclinical trials in Inflammation in Switzerland (unspecified route)